ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626676 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626676; 2) Community: the network communities that were significantly associated with the response to NSC 626676; 3) Molecule: the relationships between components within communities and NSC 626676; 4) MDR: the compounds that were significantly associated with the NSC 626676.

NSC Compound Enrichment Correlation
NSC 665773 Null 0.0133986477026051 0.36721667
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.0133986477026051 0.090070131
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.0133986477026051 0.052563686
NSC 683555 Camptothecin Derivative 0.0133986477026051 0.11422336
NSC 690266 ANTINEOPLASTIC-690266 0.0133986477026051 0.36560344
NSC 696864 Null 0.0133986477026051 0.29805296
NSC 697568 Null 0.0133986477026051 0.24134476
NSC 700552 4-Quinolinone, 6-bromo-1,2,3,4-tetrahydro-1-[(4-methylphenyl)sulfonyl]- 0.0133986477026051 0.15097002
NSC 701759 Null 0.0133986477026051 0.1967877
NSC 708785 Null 0.0133986477026051 0.22461316
Total:104  Current:50    [First] [Prev] [Next] [Last]